Mainly ovarian cancer proceeds without any symptoms during the first stage. Besides, the first symptoms (increased stomach) are very often considered adnexitis ( inflammation of the ovaries) Tumor is gradually spread over the abdominal cavity affecting the omentum and causing fluid accumulation (ascite...
SURVIVAL rateOVARIAN cancerGYNECOLOGIC cancerDELAYED diagnosisSYMPTOMSDEATH rateOvarian cancer is amongst one of the most commonly occurring cancers affecting women, and the leading cause of gynecologic related cancer death. Its poor prognosis and high mortality rates can be attributed to the absence of ...
However, the five-year average survival rate for all women diagnosed with ovarian cancer is only 50.8%. This is because it is often found at an advanced stage in which the disease has already spread within the abdomen. Survival is also dependent on the type of care the patient receives. ...
Ovarian cancer is difficult to diagnose because symptoms often do not occur until late in the disease. Symptoms do not occur until the tumor has grown large enough to apply pressure to other organs in the abdomen, or until the cancer has spread to remote organs. The symptoms are nonspecific,...
Prognosis of a cancer is often described in terms of the 5-year survival rate. This indicates the percentage of patients who survive or live 5 years or more after diagnosis of the cancer. The type of ovarian cancer also determines its prognosis. On the whole, the 5-year survival rate of...
Ovarian cancer is the leading cause of death among women with gynecological cancer, with an overall 5-year survival rate below 50% due to a lack of specific symptoms, late stage at time of diagnosis and a high rate of recurrence after standard therapy. A better understanding of heterogeneity,...
Ovarian cancer has the highest mortality rate among gynecologic tumors, with a 5-year survival rate of less than 25%. There is an urgent need for early diagnosis and new drugs to reduce the disease burden of ovarian cancer. The aim of this study was to investigate the effectiveness of SLC...
aOvarian cancer has one of the highest mortality rates of all gynecologic malignant tumors. More than 70% of patients are late-stage at diagnosis [1], and the 5-year survival rate is approximately 19~40% [2-3]. Locoregional recurrence and distant metastases are ominous events in patients wi...
(version 1.2023), there are many therapeutic regimens for resistant ovarian cancer, including some novel agents. However, the objective remission rate is still low, and the median survival time is less than 12 months due to complicated resistance mechanisms. In resistant ovarian cancer, the ...
Screening for Ovarian Cancer: An Evidence Review for the US Preventive Services Task Force: Evidence Synthesis No. 157. Rockville, MD: Agency for Healthcare Research and Quality; 2018. AHRQ publication 17-05231-EF-1. 4. Henderson JT, Webber EM, Sawaya GF. Screening for ovarian cancer: an ...